Abbott Laboratories (ABT)
Reasons to Retain ABT Stock in Your Portfolio Now
Investors feel optimistic about Abbott's robust strength in the EPD and Nutrition businesses. Yet, unfavorable forex impacts are concerning.
ABT Stock Up on First Successful LBBAP Procedures With AVEIR Pacemaker
Abbott completes the world's first leadless pacing procedures in the left bundle branch of the heart.
The Smartest Dividend Stocks to Buy With $500 Right Now
As an investor, your goal is to select quality stocks that will advance over a period of years -- but this doesn't mean you have to wait a long time for all of the rewards. If you add a few dividend stocks to your portfolio, you'll start collecting returns on a regular basis -- without lifting a finger.
Abbott (ABT) Increases Despite Market Slip: Here's What You Need to Know
In the latest trading session, Abbott (ABT) closed at $113.29, marking a +0.59% move from the previous day.
Abbott (ABT) Stock Sinks As Market Gains: Here's Why
In the closing of the recent trading day, Abbott (ABT) stood at $114.14, denoting a -1.18% change from the preceding trading day.
Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note
In the latest trading session, Abbott (ABT) closed at $115.59, marking a -0.33% move from the previous day.
Brokers Suggest Investing in Abbott (ABT): Read This Before Placing a Bet
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock
Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors
In the closing of the recent trading day, Abbott (ABT) stood at $118.77, denoting a -0.15% change from the preceding trading day.
ABT Stock Benefits From First Patient Procedures With TAVI System
Abbott announces its investigational TAVI balloon-expandable system???s first patient procedures.
Abbott Laboratories: Investors Should Wait For A Pullback
Abbott has a very stable gross profit margin, while the company's revenue and return on invested capital could be more consistent. The company has increased their dividend for more than 50 years and should announce their 53rd dividend increase in December. Considering ABT is trading for a slight premium and has a long-term expected rate of return of 8%, potential investors will need to be patient.
2 Dividend Kings to Buy for a Lifetime of Passive Income
2 Dividend Kings to Buy for a Lifetime of Passive Income
